Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of saudi arabia, an emerging high-risk area

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5671-5674

  Hasan, Tarique Noorul ^a   Shafi, Gowhar ^a   Syed, Naveed Ahmed ^a   Alsaif, Mohammed Abdullah ^b   Alsaif, Abdulaziz Abdullah ^c   Alshatwi, Ali Abdullah ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

BRCA1; BRCA2; Breast cancer; Saudi arabia; Single nucleotide polymorphism

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; BREAST NEOPLASMS; ETHNIC GROUP; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INCIDENCE; MIDDLE AGED; RISK; RISK FACTOR; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RISK FACTORS; SAUDI ARABIA;

EID: 84890491106     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5671     Document Type: Article

References (23)

1. Agalliu I, Kwon EM, Salinas CA, et al (2010). Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control, 21, 289-300.
2. Alshatwi AA, Shaf G, Hasan TN, et al (2011). Single nucleotide polymorphisms in the p21 and bcl2 cancer susceptibility genes and breast cancer risk in Saudi Arabia. Asian Pac J Cancer Prev, 12, 2607-10.
3. Bin Amer SM, Maqbool Z, Nirmal MS, et al (2008). Gene expression profiling in women with breast cancer in Saudi population. Saudi Med J, 29, 507-13.
4. Cox DG, Kraft P, Hankinson SE, Hunter DJ (2005). Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res, 7, 171-5.
5. Cox DG, Hankinson SE, Hunter DJ (2005). No association between BRCA2 N372H and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 1353-4.
6. Elkum N, Dermime S, Tulbah A (2007). Age 40 and younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer, 5, 222.
7. Ezzat AA, Ibrahim EM, Raja MA, (1999). Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol, 16, 95-103.
8. Ford D, Easton DF, Stratton M, et al (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet, 62, 676-89.
9. Gayther SA, Warren W, Mazoyer S, et al (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet, 11, 428-33.
10. Huo X, Lu C, Huang X, et al (2009). Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J Cancer Res Clin Oncol, 135, 1569-75.
11. Jiao J, Zheng T, Lan Q, et al (2012). Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non- Hodgkin's lymphoma. Eur J Cancer Prev, 21, 580-4.
12. Kruglyak L (1999). Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet, 22, 139-44.
13. Ma H, Jin G, Hu Z, et al (2006). Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Int J Cancer, 119, 2173-8.
14. Nicoloso MS, Sun H, Spizzo R, et al (2010). Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res, 70, 2789-98.
15. Palli D, Falchetti M, Masala G, et al (2007). Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy. BMC Cancer, 3, 170.
16. Pharoah PD, Antoniou A, Bobrow M, et al (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet, 31, 33-6.
17. Reedy M, Gallion H, Fowler JM, Kryscio R, Smith SA (2002). Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol, 85, 255-9.
18. Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS (2006). Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood, 108, 638-44.
19. Sehl ME, Langer LR, Papp JC, et al (2009). Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res, 15, 2192-203.
20. Song CG, Hu Z, Wu J, et al (2006). The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol, 132, 617-26.
21. Spurdle AB, Hopper JL, Chen X, et al (2002). The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev, 11, 413-6.
22. Venter JC, Adams MD, Myers EW, et al (2001). The sequence of the human genome. Science, 291, 1304-51.
23. Wu X, Zhao H, Suk R, Christiani DC (2004). Genetic susceptibility to tobacco-related cancer. Oncogene, 23, 6500-23.